MedTrace Logo

Oral Propranolol for Reducing Pediatric Dental Patients Anxiety

NCT03388957 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-03-24

No results posted yet for this study

Summary

Evaluating anxiety, heart rate and behavior during dental extractions after oral dose of either Propranolol, Midazolam or a combination of both in uncooperative pediatric patients.

Conditions

  • Extrusion of Tooth

Interventions

DRUG

Propranolol

This drug will be given before the extraction procedure

DRUG

Midazolam

This drug will be given before the extraction procedure

Sponsors & Collaborators

  • Damascus University

    lead OTHER

Principal Investigators

  • Omar Abu Bakr, DDS · MSc student in Pedodontics, University of Damascus Dental School, Damascus, Syria

  • Mohamed Altinawi, DDS MSc PhD · Professor of Pedodontics, University of Damascus Dental School, Damascus, SYRIA

  • Youssef Latifeh, MD MSc Phd · Professor and Head of the Psychiatry Department, Damascus Univesrity, Damascus, Syria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-30
Primary Completion
2019-10-01
Completion
2020-02-15

Countries

  • Syria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03388957 on ClinicalTrials.gov